Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS
- PMID: 20307581
- DOI: 10.1016/j.bbr.2010.03.026
Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS
Abstract
This study aimed to find the most sensitive brain region of APP-PS1 mice in early-stage Alzheimer's disease (AD) and to compare the findings with wild-type mouse brain using (1)H high resolution magic angle spectroscopy (HR-MAS). At 18 and 35 weeks of age, the object recognition test was performed with both APP-PS1 and wild-type mice, and the metabolite concentrations were measured in six brain regions at 38-42 weeks using (1)H HR-MAS. Compared to that of wild-type mice, the memory index of the APP-PS1 mice at 18 weeks was not significantly different; however, the memory index of the APP-PS1 mice at 35 weeks was significantly lower. Similar to the results of the (1)H HR-MAS, the [N-acetyl aspartate (NAA)+acetate (Acet)] level in APP-PS1 mice was decreased in the hippocampus and temporal cortex, and the myo-inositol (mIns) level was increased in the entire brain. In addition, scyllo-inositol (sIns) was also elevated in the frontal, occipital, and parietal cortices, hippocampus and thalamus. These findings demonstrated that the behavioral abnormalities of the APP-PS1 mice started at about 30 weeks of age and that the hippocampus and temporal cortex were the most sensitive regions during early-stage AD. In addition, the results of this study confirmed that an increase of mIns and sIns precedes the reduction of the NAA level. These findings demonstrated that the metabolism of the APP-PS1 mouse was associated with early-stage AD. Furthermore, the regional neurochemical profile of APP-PS1 mouse can be used to investigate the pathophysiological mechanisms associated with AD.
Copyright 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.Neurobiol Aging. 2009 Jan;30(1):54-70. doi: 10.1016/j.neurobiolaging.2007.05.004. Epub 2007 Jun 11. Neurobiol Aging. 2009. PMID: 17561313
-
Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.J Exp Biol. 2009 Feb;212(Pt 4):494-8. doi: 10.1242/jeb.022780. J Exp Biol. 2009. PMID: 19181896
-
Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.Neurobiol Dis. 2006 Sep;23(3):653-62. doi: 10.1016/j.nbd.2006.05.010. Epub 2006 Jul 10. Neurobiol Dis. 2006. PMID: 16829076
-
Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jan-Feb;2(1):35-47. doi: 10.1002/wnan.59. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010. PMID: 20049829 Review.
-
Metabolism of presenilin 1: influence of presenilin 1 on amyloid precursor protein processing.Neurobiol Aging. 1998 Jan-Feb;19(1 Suppl):S15-8. doi: 10.1016/s0197-4580(98)00026-8. Neurobiol Aging. 1998. PMID: 9562461 Review.
Cited by
-
Neuroimaging of Mouse Models of Alzheimer's Disease.Biomedicines. 2022 Jan 28;10(2):305. doi: 10.3390/biomedicines10020305. Biomedicines. 2022. PMID: 35203515 Free PMC article. Review.
-
A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 mice.PLoS One. 2013 May 22;8(5):e63643. doi: 10.1371/journal.pone.0063643. Print 2013. PLoS One. 2013. PMID: 23717459 Free PMC article.
-
The effects of aging, housing and ibuprofen treatment on brain neurochemistry in a triple transgene Alzheimer's disease mouse model using magnetic resonance spectroscopy and imaging.Brain Res. 2014 Nov 24;1590:85-96. doi: 10.1016/j.brainres.2014.09.067. Epub 2014 Oct 6. Brain Res. 2014. PMID: 25301691 Free PMC article.
-
Anodal Transcranial Direct Current Stimulation Can Improve Spatial Learning and Memory and Attenuate Aβ42 Burden at the Early Stage of Alzheimer's Disease in APP/PS1 Transgenic Mice.Front Aging Neurosci. 2020 May 13;12:134. doi: 10.3389/fnagi.2020.00134. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32595486 Free PMC article.
-
Identification of IGF-1 Effects on White Adipose Tissue and Hippocampus in Alzheimer's Disease Mice via Transcriptomic and Cellular Analysis.Int J Mol Sci. 2024 Feb 22;25(5):2567. doi: 10.3390/ijms25052567. Int J Mol Sci. 2024. PMID: 38473814 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases